CION Ameerpet
Autoimmune Disease, Transplant & Contraindications
Who Should Not Have Immunotherapy — and Why It Is Rarely a Flat No
If you have been told immunotherapy is risky or impossible for you, you were probably not told why. There are only a handful of situations where the answer is a genuine, permanent no. Far more often the risk is graded, tied to how well another condition is controlled, and reviewed by a team rather than decided by one doctor. NCCN, ASCO and ESMO guidance all treat immunotherapy contraindications this way — as risk to be stratified, not as a fixed list of disqualifications.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Very few reasons are truly absolute — A functioning organ transplant, a past life-threatening immune reaction and pregnancy are the clearest. Most other reasons are graded.
- Autoimmune disease is not an automatic no — Severity, current activity and the medication controlling it matter far more than the diagnosis label itself.
- A no can be current rather than permanent — A controlled flare, a safely reduced steroid dose or improved organ function can move a decision made months ago.
- The decision belongs to a team, not one doctor — Your oncologist, the specialist who already treats you and, where relevant, your transplant team decide together.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The honest short answer
What Are the True Contraindications to Immunotherapy?
Genuinely absolute contraindications are few. Checkpoint-inhibitor immunotherapy is usually ruled out for a functioning organ transplant on immunosuppression, severe uncontrolled autoimmune disease, sustained high-dose steroids for another condition, a previous life-threatening immune reaction to the same drug class, and pregnancy. Everything else on the usual list is a graded risk, not a locked door.
A functioning organ transplant
A transplanted organ is protected by daily immunosuppression. Immunotherapy releases immune brakes. The two pull against each other, and the graft can be rejected.
Severe, active autoimmune disease
Disease that is currently flaring, or that threatens an organ, can be made significantly worse. Teams usually defer treatment until it is controlled.
Sustained high-dose immunosuppression
High-dose steroids or strong immunosuppressants taken for a separate illness change the risk picture. Low, physiologic doses usually do not.
A previous life-threatening immune reaction
If the same class of treatment once caused a severe reaction such as myocarditis, re-treatment with that class is generally not offered again.
Unstable major organ disease or very poor fitness
Uncontrolled heart, lung, liver or kidney disease, or being too unwell for daily activities, usually means treatment is deferred rather than started.
Pregnancy
Immunotherapy is not given during pregnancy. Contraception is advised during treatment and for a period afterwards, which your oncologist will define.
This list is the general framework used across NCCN, ASCO and ESMO guidance. It is not a verdict on your case. Your own history decides which of these, if any, applies to you.
Did you know?
Most of what patients hear as "you cannot have immunotherapy" is a relative contraindication, not an absolute one. The answer can change once an autoimmune condition is brought under control, or a steroid dose is safely reduced. It is always worth asking which kind of no you were given.
Relative vs absolute
What Is the Difference Between a Relative and an Absolute Contraindication?
An absolute contraindication means the risk is judged unacceptable in almost every case, so treatment is not offered. A relative contraindication means the risk is real but weighable — against your cancer, your alternatives and how well the condition is controlled. In immunotherapy, most contraindications are relative. Very few are truly absolute.
| Situation | How it is usually graded | What usually happens next |
|---|---|---|
| Functioning solid-organ transplant on immunosuppression | Closest to absolute | Rarely offered; only ever considered jointly with the transplant team, with graft-rejection risk explained first |
| Previous life-threatening immune reaction to the same drug class | Closest to absolute | Re-treatment with that class is generally not offered |
| Pregnancy | Treated as absolute while pregnant | Not given; contraception advised during and after treatment |
| Severe, active or organ-threatening autoimmune disease | Relative — high risk | Usually deferred; may be reconsidered if the condition is brought under control |
| Sustained high-dose steroids or immunosuppressants for another illness | Relative — high risk | The team first checks whether the dose can safely be reduced |
| Mild, well-controlled autoimmune condition (treated thyroid disease, limited psoriasis) | Relative — lower risk | Often proceeds, with closer monitoring and a written flare plan |
| Chronic hepatitis B or C, or HIV on stable treatment | Relative — specialist-dependent | Frequently possible with infectious-disease input and monitoring |
| Very poor performance status or unstable major organ disease | Relative — situation-dependent | Deferred until fitness improves, or a different approach is chosen |
Risk here is stratified, not binary. The same diagnosis can sit in different rows for two different people, depending on severity, current activity and medication.
Who makes the call
Who Decides Whether Immunotherapy Is Too Risky for You?
Not one doctor. The call is made by a multidisciplinary tumor board — your medical oncologist plus, where relevant, the specialist who treats your autoimmune condition, your transplant team, a cardiologist or a pulmonologist. Guideline bodies such as NCCN, ASCO and ESMO set the framework. Your team applies it to your specific history.
- Your medical oncologist — frames the cancer side: type, stage, and what the alternatives realistically are.
- The specialist who already treats you — your rheumatologist, gastroenterologist, endocrinologist or dermatologist knows how severe your condition really is.
- Your transplant team, if you have one — no transplant patient should be assessed for immunotherapy without them in the room.
- Organ specialists where a baseline is abnormal — cardiology, pulmonology, hepatology or infectious diseases, depending on what the workup shows.
- You — you should be told which specific risk applies, how serious it is, and what would change the answer.
Ask for the reason, not just the verdict. "Immunotherapy is not suitable for you" is not an explanation. A reasonable answer names the specific contraindication, says whether it is relative or absolute, and says what, if anything, could change it.
At CION, immunotherapy is given as a day-care infusion, and eligibility is reviewed by a tumor board rather than by a single doctor — so the reasoning behind a yes or a no can always be explained back to you.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask for the Reason Behind the No
A tumor-board review reads your actual history — transplant, autoimmune disease, steroids — before deciding what is safe.
The most common worry
Does an Autoimmune Disease Mean You Can Never Have Immunotherapy?
No. Having an autoimmune disease does not automatically rule out immunotherapy. What matters is which condition, how severe it has been, whether it is currently active, and what medication controls it. Well-controlled, mild autoimmune conditions are often treated case by case. Severe, active or organ-threatening ones are where teams usually say no.
The reason is mechanical, not arbitrary. Checkpoint-inhibitor immunotherapy works by lifting the brakes your immune system normally keeps on itself. An autoimmune condition is, by definition, an immune system already attacking your own tissue. Lifting those brakes can make that attack worse. How much worse depends largely on how quiet the condition is to begin with.
That is why two people with the same diagnosis can get different answers. Someone whose rheumatoid arthritis has been stable for years on a low-dose regimen is in a different position from someone in an active flare on high-dose steroids. The same applies to inflammatory bowel disease, where the risk of a serious gut reaction is graded particularly carefully and the decision is usually made jointly with your gastroenterologist.
Tell your oncologist about every autoimmune diagnosis, even an old or mild one. Thyroid disease treated years ago, psoriasis that has settled, coeliac disease, vitiligo — all of it belongs in the conversation, because it changes what your team monitors after treatment starts.
Did you know?
Steroid dose matters more than the word "steroid". Low, physiologic doses are usually acceptable; sustained high doses taken for another illness are the concern. This is why your team asks for every medicine you take, including inhalers, joint injections and short courses for a chest infection, not just the cancer ones.
Before the decision is made
What Does Your Team Check Before Deciding?
Before deciding, your team reviews five things: your full autoimmune and transplant history, every medicine you take including steroids, baseline blood and organ-function tests, hormone and thyroid baselines, and any past reaction to a similar treatment. Nothing on this list is optional. Missing one is how avoidable risk gets missed.
- 1
Full autoimmune and transplant history
Every diagnosis, however old or mild, including anything managed by another specialist.
- 2
A complete medication list
Steroids in any form, immunosuppressants, biologics, and anything you take without a prescription.
- 3
Baseline blood and organ-function tests
Liver, kidney, blood counts and inflammatory markers, so that any later change can be recognised as a change.
- 4
Hormone and thyroid baselines
Thyroid and, where indicated, adrenal and pituitary hormone levels, since these are among the systems most often affected.
- 5
Any previous reaction to a similar treatment
A severe past immune reaction to the same drug class is one of the few findings that closes the door outright.
Our page on the pre-treatment workup before starting immunotherapy goes through each of these tests in detail, including what the results mean and how long they take.
If it is ruled out
What Happens If the Answer Is No?
A no to immunotherapy is not a no to treatment. Depending on your cancer type and stage, chemotherapy, targeted therapy, radiation or surgery may all still be open, and you can ask whether a clinical trial is worth exploring. For some people, careful monitoring or comfort-focused care is a reasonable, informed choice. Ask which of these applies to you.
- Ask whether the no is permanent or current — a deferred decision and a closed door are very different things.
- Ask what would need to change — a controlled flare, a safely reduced steroid dose, or better organ function can move the answer.
- Ask what is recommended instead — and why that option is the better fit for your cancer, not simply the safer one.
- Ask whether a trial is worth exploring — trial information is worth understanding, though eligibility and outcome are never promised in advance.
- Ask for it in writing — a written summary of the reasoning is easier to take to a second opinion than a remembered conversation.
Choosing not to treat is also a real option for some people, and saying so out loud is not giving up. Where the burden of treatment would outweigh what it can realistically offer, monitoring and symptom-focused care is a legitimate, informed choice that your team should be willing to discuss with you.
If nobody has explained why immunotherapy was ruled out, a second opinion is reasonable. You can read how the whole pathway fits together on our immunotherapy overview page.
Before you accept the answer
A Second Read on a Risk Decision Is Always Reasonable
If you were told immunotherapy is not possible and never told why, a second opinion costs you nothing but an appointment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Contraindications to Immunotherapy: Your Questions Answered
What are the true contraindications to immunotherapy?
Genuinely absolute contraindications are few. Checkpoint-inhibitor immunotherapy is usually ruled out where there is a functioning solid-organ transplant on immunosuppression, severe uncontrolled autoimmune disease, sustained high-dose steroids or strong immunosuppressants taken for another illness, a previous life-threatening immune reaction to the same drug class, or pregnancy. Very poor overall fitness and unstable major organ disease also commonly rule it out, at least for now. Almost everything else on the usual contraindication list is a graded risk rather than a locked door. The risk is weighed against your cancer, your alternatives, and how well the other condition is controlled. NCCN, ASCO and ESMO guidance all frame it this way.
What is the difference between a relative and an absolute contraindication?
An absolute contraindication means the risk is judged unacceptable in almost every case, so the treatment is not offered at all. A relative contraindication means the risk is real but weighable, against how aggressive your cancer is, what alternatives exist, and how well the other condition is currently controlled. In immunotherapy, most contraindications are relative. Very few are truly absolute. This distinction matters because patients are often told simply that immunotherapy is not possible, when what was meant is that the risk is too high right now and may be reconsidered later. It is reasonable to ask which of the two you were given.
Who decides whether immunotherapy is too risky for me?
Not one doctor. The decision is made by a multidisciplinary tumor board, which is your medical oncologist together with, where relevant, the specialist who manages your autoimmune condition, your transplant team, a cardiologist, a pulmonologist or an infectious-disease physician. Guideline bodies such as NCCN, ASCO and ESMO set the framework for how these risks are graded. Your team applies that framework to your specific history rather than to a general rule. You are part of that conversation too. You should be told which specific risk applies to you, how serious it is, and what would change the answer.
Does having an autoimmune disease mean I can never have immunotherapy?
No. An autoimmune diagnosis does not automatically rule out immunotherapy. What matters is which condition you have, how severe it has been, whether it is active right now, and what medication is needed to control it. Mild, well-controlled conditions such as treated thyroid disease or limited psoriasis are often handled case by case, with closer monitoring and a written plan for what to do if symptoms flare. Severe, active or organ-threatening autoimmune disease, or disease needing sustained high-dose immunosuppression, is where teams usually decline. The safest step is a joint discussion between your oncologist and the specialist who already treats you.
Can someone with an organ transplant have immunotherapy?
This is the situation closest to a true absolute contraindication. A transplanted organ is kept safe by daily immunosuppression, and checkpoint-inhibitor immunotherapy works by releasing immune brakes, so the two pull in opposite directions. There is a real risk of the graft being rejected. It is therefore rarely offered. Where it is considered at all, it happens only as a joint decision between your oncologist and your transplant team, with the risk to the graft explained in plain terms first. If you have had a transplant, tell your oncologist before any treatment discussion begins, not after.
If I am told immunotherapy is too risky, what are my other options?
A no to immunotherapy is not a no to treatment. Depending on your cancer type and stage, chemotherapy, targeted therapy, radiation, surgery or a combination of these may still be open to you, and you can ask your team whether a clinical trial is worth exploring. For some people, careful monitoring, or care focused on comfort and quality of life, is a reasonable and informed choice rather than a defeat. Ask your team to name the specific reason immunotherapy was ruled out, whether it could change, and what they recommend instead. A second opinion is always reasonable if the reasoning was never explained.